IS4798A - Ný pyrrolecarboxamide efnasambönd; nýr flokkur efna, sem tengist GABA viðtökum í heila - Google Patents

Ný pyrrolecarboxamide efnasambönd; nýr flokkur efna, sem tengist GABA viðtökum í heila

Info

Publication number
IS4798A
IS4798A IS4798A IS4798A IS4798A IS 4798 A IS4798 A IS 4798A IS 4798 A IS4798 A IS 4798A IS 4798 A IS4798 A IS 4798A IS 4798 A IS4798 A IS 4798A
Authority
IS
Iceland
Prior art keywords
new
pyrrolecarboxamide
brain
compounds
gaba receptors
Prior art date
Application number
IS4798A
Other languages
English (en)
Icelandic (is)
Inventor
Albaugh Pamela
Liu Gang
Shaw Kenneth
Hutchison Alan
Original Assignee
Neurogen Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corporation filed Critical Neurogen Corporation
Publication of IS4798A publication Critical patent/IS4798A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
IS4798A 1996-01-19 1998-07-16 Ný pyrrolecarboxamide efnasambönd; nýr flokkur efna, sem tengist GABA viðtökum í heila IS4798A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/588,711 US5804686A (en) 1996-01-19 1996-01-19 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
PCT/US1997/000519 WO1997026243A1 (en) 1996-01-19 1997-01-14 Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands

Publications (1)

Publication Number Publication Date
IS4798A true IS4798A (is) 1998-07-16

Family

ID=24354983

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4798A IS4798A (is) 1996-01-19 1998-07-16 Ný pyrrolecarboxamide efnasambönd; nýr flokkur efna, sem tengist GABA viðtökum í heila

Country Status (26)

Country Link
US (2) US5804686A (cg-RX-API-DMAC7.html)
EP (1) EP1019372B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000503321A (cg-RX-API-DMAC7.html)
KR (1) KR100490108B1 (cg-RX-API-DMAC7.html)
CN (1) CN1209805A (cg-RX-API-DMAC7.html)
AP (1) AP1015A (cg-RX-API-DMAC7.html)
AT (1) ATE322480T1 (cg-RX-API-DMAC7.html)
AU (1) AU1746697A (cg-RX-API-DMAC7.html)
BG (1) BG102634A (cg-RX-API-DMAC7.html)
BR (1) BR9707051A (cg-RX-API-DMAC7.html)
CA (1) CA2243317C (cg-RX-API-DMAC7.html)
CZ (1) CZ215498A3 (cg-RX-API-DMAC7.html)
DE (1) DE69735647T2 (cg-RX-API-DMAC7.html)
ES (1) ES2263170T3 (cg-RX-API-DMAC7.html)
HU (1) HUP9901018A3 (cg-RX-API-DMAC7.html)
IL (1) IL125391A (cg-RX-API-DMAC7.html)
IS (1) IS4798A (cg-RX-API-DMAC7.html)
MX (1) MX9805701A (cg-RX-API-DMAC7.html)
NO (1) NO312670B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ330861A (cg-RX-API-DMAC7.html)
OA (1) OA10811A (cg-RX-API-DMAC7.html)
PL (1) PL327936A1 (cg-RX-API-DMAC7.html)
RU (1) RU2167151C2 (cg-RX-API-DMAC7.html)
SK (1) SK94398A3 (cg-RX-API-DMAC7.html)
UA (1) UA49001C2 (cg-RX-API-DMAC7.html)
WO (1) WO1997026243A1 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US6211365B1 (en) 1996-01-19 2001-04-03 Neurogen Corporation Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
AU2218997A (en) * 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
US5723462A (en) * 1996-04-26 1998-03-03 Neurogen Corporation Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
GT199800179A (es) * 1997-11-13 2000-05-02 Procedimiento de sintesis de pirrol amidas.
SK6872000A3 (en) * 1997-11-13 2002-02-05 Pfizer Prod Inc Method of synthesis of pyrrole amides
WO1999043660A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
GB9812038D0 (en) 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US20050014939A1 (en) * 1999-08-31 2005-01-20 Neurogen Corporation Fused pyrrolecarboxamides: GABA brain receptor ligands
IL147971A0 (en) * 1999-08-31 2002-09-12 Neurogen Corp Fused pyrrolecarboxamides: gaba brain receptor ligands
AU2001264932A1 (en) * 2000-05-26 2001-12-11 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
JP2004508352A (ja) * 2000-09-06 2004-03-18 ニューロゲン コーポレイション 置換縮合ピロールイミン及びピラゾールイミン
JP2004508359A (ja) * 2000-09-06 2004-03-18 ニューロゲン コーポレイション アリール置換テトラヒドロインダゾール、及び、gaba−a受容体に対するリガンドとしてのそれらの使用
AU2002210855A1 (en) * 2000-12-04 2002-06-18 Pfizer Products Inc. Synthesis of fused pyrrolecarboxamides
BR0307504A (pt) * 2002-02-07 2004-12-07 Neurogen Corp Composto ou sal farmaceuticamente aceitável, composição farmacêutica, métodos tratar doenças, para potencializar um efeito terapêutico de um agente para o snc, para melhorar a memória de curto prazo em um paciente, para determinar a presença ou ausência de receptores gabaa em uma amostra, e para alterar a atividade transdutora de sinal do receptor gabaa, embalagem, e, uso de um composto ou sal
JP2006502974A (ja) * 2002-05-17 2006-01-26 ニューロジェン コーポレイション 置換環縮合イミダゾール誘導体:gabaa受容体リガンド
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
KR20090064418A (ko) 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
NZ576036A (en) 2006-10-16 2010-10-29 Bionomics Ltd Naphthyridine containing compounds for treating anxiety disorders
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TR201816134T4 (tr) 2010-08-31 2018-11-21 Meiji Seika Pharma Co Ltd Zararli kontrol ajani
CA2828780A1 (en) 2011-03-02 2012-09-07 Bionomics Limited Novel small-molecules as therapeutics
US9133188B2 (en) 2011-05-12 2015-09-15 Bionomics Limited Methods for preparing naphthyridines
CN120081825B (zh) * 2025-05-07 2025-09-16 天津匠新致成科技有限公司 一种化合物及其制备方法和医药用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) * 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3147276A1 (de) * 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3246932A1 (de) * 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
AU652968B2 (en) * 1990-10-09 1994-09-15 Neurogen Corporation Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
EP0626966A1 (en) * 1992-02-19 1994-12-07 PHARMACIA & UPJOHN COMPANY 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
AU6098194A (en) * 1993-01-29 1994-08-15 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
FR2705095B1 (fr) * 1993-05-12 1995-06-23 Adir Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
NO312670B1 (no) 2002-06-17
IL125391A (en) 2004-07-25
BG102634A (en) 1999-08-31
BR9707051A (pt) 1999-07-20
NO983315D0 (no) 1998-07-17
WO1997026243A1 (en) 1997-07-24
HUP9901018A3 (en) 1999-11-29
IL125391A0 (en) 1999-03-12
US6080873A (en) 2000-06-27
HUP9901018A2 (hu) 1999-07-28
KR19990077300A (ko) 1999-10-25
MX9805701A (es) 1998-11-30
DE69735647T2 (de) 2007-05-03
US5804686A (en) 1998-09-08
AU1746697A (en) 1997-08-11
PL327936A1 (en) 1999-01-04
CN1209805A (zh) 1999-03-03
RU2167151C2 (ru) 2001-05-20
CA2243317C (en) 2007-09-25
SK94398A3 (en) 1999-02-11
NO983315L (no) 1998-09-03
OA10811A (en) 2001-07-05
KR100490108B1 (ko) 2005-11-25
ATE322480T1 (de) 2006-04-15
ES2263170T3 (es) 2006-12-01
UA49001C2 (uk) 2002-09-16
NZ330861A (en) 2000-03-27
CZ215498A3 (cs) 1999-09-15
AP1015A (en) 2001-09-28
JP2000503321A (ja) 2000-03-21
AP9801297A0 (en) 1998-09-30
EP1019372B1 (en) 2006-04-05
DE69735647D1 (de) 2006-05-18
EP1019372A1 (en) 2000-07-19
CA2243317A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
IS4798A (is) Ný pyrrolecarboxamide efnasambönd; nýr flokkur efna, sem tengist GABA viðtökum í heila
IS5071A (is) Ný efnasambönd með verkjadeyfandi áhrif
IS5078A (is) Ný efnasambönd með verkjadeyfandi áhrif
PT738150E (pt) Antagonistas biciclicos de fibrinogenio
FI964576A7 (fi) Uusia agonistiyhdisteitä
AU2519599A (en) New oxazolidinones with azol-containing tricycles
ID16298A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena yang disubstitusi
IS5382A (is) Setin 4-oxo-napthyridine-3-karboxamíð sem tengistGABA viðtökum í heila
FI973176L (fi) Selektiivisinä dopamiini-D3-ligandeina toimivia 2-aminoindaaneja
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
IS6290A (is) Sameinuð pirrolecarboxamíð; GABA viðtakar í heila
DK0726265T3 (da) 10-Aminoaliphatyl-dibenz[b,f]oxepiner med antineurodegenerativ virkning
ID22131A (id) Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
DE69504067D1 (de) Dreifach substituiert ingesättigte polymere
TR199801432A3 (tr) Rasemizasyona karsi stabilize edilmis farmakolojik silansetron karisimlari.
IS4768A (is) Ný efnasambönd sem hafa verkjastillandi áhrif
HRP970204B1 (en) New retinoids
DE69711255D1 (de) Motorrad
FR2723065B3 (fr) Greement notamment pour bicyclette
GB9601332D0 (en) New ways to tell the time
IT241909Y1 (it) Macchina impanatrice
ZA976591B (en) Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
GB9803478D0 (en) New all purpose bicycle
GB9722101D0 (en) New all purpose bicycle
ZA9711059B (en) Novel compounds with analgesic effect.